|本期目录/Table of Contents|

[1]徐英,刘峥,彭绩,等.2001—2015 年深圳市宝安区甲状腺癌发病趋势分析[J].慢性病学杂志,2018,(02):125-128.
 XU Ying*,LIU Zheng,Peng Ji,et al.Trend in incidence of thyroid cancer in Baoan district of Shenzhen, 2001-2015[J].,2018,(02):125-128.
点击复制

2001—2015 年深圳市宝安区甲状腺癌发病趋势分析(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2018年02期
页码:
125-128
栏目:
论著
出版日期:
2018-02-01

文章信息/Info

Title:
Trend in incidence of thyroid cancer in Baoan district of Shenzhen, 2001-2015
作者:
徐英1 刘峥1 彭绩2 雷林2 赵仁成1 黄宝珍1 郭艳芳1
1. 深圳市宝安区慢性病防治院慢性非传染性疾病防治科/慢性病防治研究所,广东深圳518100; 2. 深圳市慢性病防治中心慢病科,广东深圳518100
Author(s):
XU Ying* LIU Zheng Peng Ji LEI Lin ZHAO Ren-cheng HUANG Bao-zhen GUO Yan-fang
* Department of Chronic Non-communicable Disease Prevention and Control, Baoan Chronic Diseases Prevent and Cure Hospital, Shenzhen, Guangdong 518101, China Corresponding author: GUO Yan-fang, E-mail: 3177167052@qq.com
关键词:
甲状腺癌发病率年龄分布流行趋势
Keywords:
Thyroid neoplasms Incidence Age distribution Temporal trend
分类号:
R736.1
DOI:
-
摘要:
目的分析深圳市宝安区甲状腺癌发病年龄分布和流行趋势。方法利用深圳市肿瘤监测系统2001— 2015年宝安区甲状腺癌的数据,分别计算粗发病率、年龄别发病率、中国人口标化率(中标率) 和世界人口变化 率(世标率),采用Joinpoint模型对15 年间粗发病率和年龄变化趋势进行分析。结果2001—2015 年宝安区甲 状腺癌累计报告1 383 例,平均发病年龄36.9 岁,粗发病率由2001 年的0.69/10 万上升至2015 年的9.53/10 万, 中标率和世标率也分别由1.11/10 万、1.42/10 万上升至10.11/10 万、11.87/10 万。Joinpoint回归显示,15 年来 发病呈现上升趋势,总体中标率/世标率年平均增长26.6%/27.0%,其中女性年平均增长22.1%/21.3%;总体发 病年龄呈现0~10 岁快速上升、10~45 岁缓慢上升和45~岁以后下降三个区间的变化趋势,与女性年龄趋势 一致。结论深圳市宝安区甲状腺癌的发生水平低于全国或同类城区的水平,但增长速度可能较高,甲状腺癌 防控的重点人群是女性和中青年人。
Abstract:
Objective To analyze the trend and age distribution of incidence of thyroid cancer in Baoan district of Shenzhen, 2001-2015. Methods Data from Shenzhen Cancer Register were collected. The crude rates, Chinese national and world age-standardized rates of incidence of thyroid cancer were computed and Joinpoint model was employed to analyze the trend of time and the age- specific rates. Results Totally 1 383 cases were reported with average age of onset 36.9 during 2001-2015. The crude, Chinese national and world age-standardized rates of incidence increased from 0.69/105,1.11/105 and 1.42/105 in 2001 to 9.53/105, 10.11/105 and 11.87/105 in 2015. The annual percent changes (APCs) of the pooled Chinese national and world age-standardized rates of incidence were 26.6% and 27.0%, and they were 22.1% and 21.3% among the females. There were 2 join points and 3 segments for the pooled age- specific incidence rates, those were 0- 10, 10- 45 and 45 + years old, similar to the females. Conclusion The incidence rate of thyroid cancer was lower, but the growth rate might be higher than other parts of China The females and the young and middle aged adults need more control efforts in Baoan district of Shenzhen.

参考文献/References:

[1] La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview [J]. Int J Cancer, 2015,136(9):2187-2195.
[2] 董芬,张彪,单广良. 中国甲状腺癌的流行现状和影响因素[J]. 中 国癌症杂志,2016(1):47-52.
[3] Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level [J]. Chin J Cancer Res, 2017,29(1):1-10.
[4] 杨雷,郑荣寿,王宁,等.2010 年中国甲状腺癌发病与死亡情况[J]. 中华预防医学杂志,2014,48(8):663-668.
[5] 赛恒,吴岩,李炳尧,等. 甲状腺肿瘤的流行现状及危险因素研究 新进展[J].中国民康医学,2015,27(12):76-78,97.
[6] Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors [J]. J Cancer Epidemiol, 2013,2013: 965212.
[7] 刘玉琴,张书全,陈万青,等. 中国2003-2007 年甲状腺癌发病死 亡现状及流行趋势分析[J]. 中华流行病学杂志,2012,33(10): 1044-1048.
[8] 沈琪,倪翀,乔鹏,等.2002-2012 年上海市杨浦区社区人群甲状 腺癌的发病和生存情况分析[J].第二军医大学学报,2016,37(5): 569-575.
[9] 向芳,黄芳,张一英,等.2003—2013 年上海市嘉定区甲状腺癌发 病率变化趋势分析[J].中华预防医学杂志,2016,50(7):656-658.
[10] 穆慧娟,礼彦侠,张蕊,等.辽宁省五市2000~2011 年甲状腺癌发 病、死亡现状及流行趋势分析[J]. 中国肿瘤,2015,24(11):889- 895.
[11] 陈和新,王娜,黄培新,等.2002—2008 年江苏省海门市甲状腺癌 流行状况分析[J].中华疾病控制杂志,2011,15(4):279-281.
[12] 李科,林国桢,周琴,等.2000—2011 年广州市城区甲状腺癌的发 病趋势分析[J].中华预防医学杂志,2015,49(2):142-146.
[13] 黄风玲,刘攀,毛睿,等.新疆地区甲状腺癌临床流行病学特征[J]. 山东医药,2015,55(37):19-21.
[14] 梁智恒,岑慧珊,魏矿荣. 广东省中山市1970~2012 年甲状腺癌 发病概况[J].中国肿瘤,2016,25(10):752-757.
[15] Tafani M, De Santis E, Coppola L, et al. Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression [J]. Biomed Pharmacother, 2014,68(1):1-5.

备注/Memo

备注/Memo:
基金项目:1. 深圳市卫计委项目(SZGW2017009);2. 深 圳市科创委项目(JCYJ20170303104937484) 作者简介:徐英,博士研究生,副主任医师,主要从事慢 性非传染性疾病防治工作 通信作者:郭艳芳,E-mail: 3177167052@qq.com
更新日期/Last Update: 2018-02-28